Scientists in Berlin have pioneered a new "carbon ion therapy" which will fire carbon ions at 73% of the speed of light for the extremely precise treatment of inoperable tumors. »»»
Researchers from the University of Washington in Seattle wanted to see how many genetic abnormalities were missed by commercial genetic testing in families that were at high risk for breast and... »»»
WHITE PLAINS, N.Y. -- The Leukemia & Lymphoma Society (LLS) has named five researchers as Stohlman Scholars, recognizing their outstanding contributions to the advancement of blood cancer research. »»»
Cancer researchers at George Mason University's Center for Applied Proteomics and Molecular Medicine are studying the effects of experimental treatments on living tumor cells taken from multiple... »»»
New research indicates that giving patients a continuous low dose of an immune system booster, a method known as metronomic dosing, as part of a therapeutic prostate cancer vaccine strategy is safe... »»»
Ariad Pharmaceuticals announced that it has initiated a Phase 2 clinical trial to examine the efficacy and safety of oral deforolimus, its investigational mTOR inhibitor, in patients with advanced... »»»
Researchers detail in 'Induction therapy in the modern era of combined-modality therapy for locally advanced head and neck cancer,' new data in head and neck cancer. »»»
Researchers detail in 'Influence of smoking on histologic type and the efficacy of adjuvant chemotherapy in resected non-small cell lung cancer,' new data in non-small cell lung cancer. »»»
Scientists using a three-dimensional cell culture system have identified a mechanism by which dormant, metastatic tumor cells can begin growing again after long periods of inactivity. »»»
SAN DIEGO -- Nventa Biopharmaceuticals Corporation today announced that it has completed analysis of immunological data from all four cohorts of its Phase 1 clinical trial for HspE7, its lead product... »»»
Amgen announced findings from a three-year pivotal Phase 3 placebo-controlled trial evaluating denosumab in the treatment of bone loss in men undergoing androgen deprivation therapy (ADT) for... »»»